跳至主要内容
临床试验/NCT01695564
NCT01695564已完成不适用

Comparison of Safety and Efficacy of Left Atrial Appendage Occlusion Devices

Kansas City Heart Rhythm Institute1 个研究点 分布在 1 个国家目标入组 169 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
169
试验地点
1
主要终点
Effect of LAA occlusion by LARIAT device

研究概览

简要总结

Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice. In the last two decades the number of hospitalizations for AF has increased two- to three-fold. More than 6 million people worldwide suffer from atrial fibrillation (AF), a cardiac disorder that results in systemic emboli. Patients with AF are 5 times more likely to have a stroke compared with those without AF.

This registry will collection information on two devices that are used to treat AF. The WATCHMAN and LARIAT. The differences in techniques and subsequent effects of the two devices on outcomes related to AF has not been studied. This study will look to compare the two devices to see how the outcomes may vary.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have had a LARIAT LAA device occlusion

排除标准

  • Patients who have PFO/ASD/critical carotid artery (>70% blockage) disease and hemorrhagic strokes

结局指标

主要结局

Effect of LAA occlusion by LARIAT device

时间窗: Change from Day 0 to 356 post-procedure

This registry will provide data on patient outcomes at different times during follow up.This includes: changes in the appendage size, shape and patients medical history.

次要结局

  • Compare effectiveness of LAA occlusion procedure by evaluating LAA jet velocities(Days 0, 90, 180, 365 post-procedure and annually thereafter)

研究者

发起方
Kansas City Heart Rhythm Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy of Left Atrial Appendage... | 临床试验